Long-lasting response to cis-platinum in recurrent malignant thymoma: case report.
A patient who had received irradiation for inoperable invasive thymoma was treated with cis-platinum after mediastinal and endothoracic recurrence two years from diagnosis. A quick and long-lasting response was observed, which is still present. Systematic phase II trials with cis-platinum in invasive thymoma are suggested.
D000368:Aged; D002945:Cisplatin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D013945:Thymoma / Q000188:drug therapy* / Q000532:radiotherapy; D013953:Thymus Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy
D002945:Cisplatin